These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
761 related articles for article (PubMed ID: 29550033)
1. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer. Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033 [TBL] [Abstract][Full Text] [Related]
2. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer. Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727 [TBL] [Abstract][Full Text] [Related]
3. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC). Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885 [TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer. Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474 [TBL] [Abstract][Full Text] [Related]
5. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer. van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764 [No Abstract] [Full Text] [Related]
6. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer. Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763 [TBL] [Abstract][Full Text] [Related]
7. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study. Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674 [TBL] [Abstract][Full Text] [Related]
8. Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simulation tool. Yamano A; Inoue T; Yagihashi T; Yamanaka M; Matsumoto K; Shimo T; Shirata R; Nitta K; Nagata H; Shiraishi S; Minagawa Y; Omura M; Tokuuye K; Chang W Radiat Oncol; 2024 Sep; 19(1):117. PubMed ID: 39252032 [TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies. Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371 [TBL] [Abstract][Full Text] [Related]
10. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy. Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083 [TBL] [Abstract][Full Text] [Related]
11. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Feng H; Shan J; Ashman JB; Rule WG; Bhangoo RS; Yu NY; Chiang J; Fatyga M; Wong WW; Schild SE; Sio TT; Liu W Med Phys; 2021 Aug; 48(8):4636-4647. PubMed ID: 34058026 [TBL] [Abstract][Full Text] [Related]
12. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer. Shang H; Pu Y; Wang Y Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663 [TBL] [Abstract][Full Text] [Related]
13. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy. Rana S; Rosenfeld AB J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458 [TBL] [Abstract][Full Text] [Related]
14. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning. Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641 [TBL] [Abstract][Full Text] [Related]
15. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis. Stützer K; Lin A; Kirk M; Lin L Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468 [TBL] [Abstract][Full Text] [Related]
16. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique. Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667 [TBL] [Abstract][Full Text] [Related]
17. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491 [TBL] [Abstract][Full Text] [Related]
18. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy. Li X; Kabolizadeh P; Yan D; Qin A; Zhou J; Hong Y; Guerrero T; Grills I; Stevens C; Ding X Radiat Oncol; 2018 Feb; 13(1):35. PubMed ID: 29486782 [TBL] [Abstract][Full Text] [Related]
19. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions. Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378 [TBL] [Abstract][Full Text] [Related]
20. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy. Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]